4568
Daiichi Sankyo is a global pharmaceutical company focused on researching, developing, and bringing medicines to patients across multiple therapeutic areas. The company emphasizes pipelines in areas such as oncology and cardiovascular diseases, and engages in open innovation and clinical trial transparency to advance medical science. With operations and research activities spanning international markets, Daiichi Sankyo aims to improve patient outcomes through innovative therapies and responsible governance.
No recent deals for this company.